I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg & the Netherlands MONTREAL, October 2, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased…
Montreal, May 24, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of a Canadian distribution agreement with ESW Vision for the patented E>Eye device. E>Eye,…
Montreal, April 3, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian Company specializing in dry eye diagnosis and management, is pleased to announce receiving regulatory approval from INVIMA in Colombia and ANMAT in Argentina for its patented I-PEN® Osmolarity…
Montreal, January 8, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with OCuSOFT Inc. for distribution rights in the United States…
MONTREAL, January 8, 2018 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of an exclusive agreement with IMEX for distribution of its I-PEN® Tear Osmolarity System and I-PLUG® punctum…
Copyright © 2018 I-MED Pharma inc. All rights reserved.
Privacy | Terms & Conditions
